Hematologic Oncology Update
522 episodes - English - Latest episode: 25 days ago - ★★★★★ - 67 ratingsFeaturing one-on-one interviews conducted by Dr Neil Love, this series provides medical oncologists with access to an array of important perspectives and information on relevant advances in the treatment of hematologic cancer to facilitate optimal patient care.
Homepage Apple Podcasts Google Podcasts Overcast Castro Pocket Casts RSS feed
Episodes
Oncology Today with Dr Neil Love: Key Presentations on Lymphoma from Recent Major Conferences
May 29, 2024 20:20 - 1 hour - 52.8 MBDr Andrew D Zelenetz from Memorial Sloan Kettering Cancer Center in New York City discusses recent updates on available and emerging treatment strategies for various lymphomas.
Oncology Today with Dr Neil Love: Recent Advances in the Treatment of Philadelphia Chromosome-Positive Acute Lymphoblastic Leukemia
May 28, 2024 19:17 - 33 minutes - 23.4 MBDr Elias Jabbour from the University of Texas MD Anderson Cancer Center in Houston discusses recent advances in the treatment of Philadelphia chromosome-positive acute lymphoblastic leukemia.
Oncology Today with Dr Neil Love: Bispecific Antibodies in the Management of Multiple Myeloma
May 24, 2024 16:31 - 42 minutes - 29 MBDr Joshua Richter from the Tisch Cancer Institute, Icahn School of Medicine at Mount Sinai in New York, New York, discusses the role of bispecific antibodies in multiple myeloma.
Year in Review: Clinical Investigator Perspectives on the Most Relevant New Data Sets and Advances in Acute Myeloid Leukemia
May 14, 2024 18:53 - 1 hour - 42.8 MBDrs Naval Daver and Courtney D DiNardo, both from The University of Texas MD Anderson Cancer Center in Houston, summarize the clinical progress in diagnosing and treating acute myeloid leukemia over the past year, as well as practical considerations for patients with the disease.
Meet The Professor: Optimizing the Management of Myelofibrosis — Part 2 of a 2-Part Series
May 02, 2024 19:13 - 1 hour - 49 MBDr Ruben A Mesa from Wake Forest University School of Medicine in Winston-Salem, North Carolina, discusses recent updates on available and novel treatment strategies for myelofibrosis.
Striving for Consensus: Current and Future Management of Paroxysmal Nocturnal Hemoglobinuria
April 26, 2024 18:03 - 1 hour - 77.9 MBDr Carlos de Castro, Prof Alexander Röth and Dr Ilene Weitz summarize the biology of paroxysmal nocturnal hemoglobinuria, current treatment approaches, and practical considerations for patients with the disease.
Oncology Today with Dr Neil Love: Key Presentations on Myeloproliferative Neoplasms from Recent Major Conferences
April 24, 2024 18:15 - 1 hour - 51.8 MBDr Naveen Pemmaraju from The University of Texas MD Anderson Cancer Center in Houston discusses updated findings from ASH 2023 on management approaches for myelofibrosis and polycythemia vera.
Oncology Today with Dr Neil Love: Key Presentations on Chronic Lymphocytic Leukemia from Recent Major Conferences
April 12, 2024 21:00 - 1 hour - 76.2 MBDr Bita Fakhri from Stanford University in Stanford, California, discusses recent updates from ASH 2023 for the management of chronic lymphocytic leukemia and Richter’s syndrome.
Year in Review: Clinical Investigator Perspectives on the Most Relevant New Data Sets and Advances in Lymphoma
March 27, 2024 16:12 - 1 hour - 56.2 MBDr Andrew M Evens from the Rutgers Cancer Institute of New Jersey in New Brunswick and Dr Sonali M Smith from the University of Chicago in Illinois discuss clinical decision-making with numerous treatment strategies for lymphoma.
Meet The Professor: Optimizing the Management of Myelofibrosis — Part 1 of a 2-Part Series
March 08, 2024 17:45 - 1 hour - 55.1 MBDr Stephen T Oh from Washington University School of Medicine in St Louis, Missouri, discusses current and emerging monitoring and management strategies for myelofibrosis.
Year in Review: Clinical Investigator Perspectives on the Most Relevant New Data Sets and Advances in Chronic Lymphocytic Leukemia
February 27, 2024 17:55 - 58 minutes - 53.9 MBDr Lindsey Roeker from Memorial Sloan Kettering Cancer Center in New York, New York, and Dr Jeff Sharman of the US Oncology Network in Eugene, Oregon, discuss relevant datasets from 2023 on the management of chronic lymphocytic leukemia.
Meet The Professor: Optimizing the Management of Acute Myeloid Leukemia and Myelodysplastic Syndromes — Part 3 of a 3-Part Series
January 17, 2024 13:34 - 1 hour - 48.4 MBDr Richard M Stone from Dana-Farber Cancer Institute in Boston discusses the optimal selection and sequencing of systemic therapies for patients with acute myeloid leukemia and myelodysplastic syndromes.
Meet The Professor: Optimizing the Management of Acute Myeloid Leukemia and Myelodysplastic Syndromes — Part 2 of a 3-Part Series
November 10, 2023 22:36 - 1 hour - 56.3 MBDr Gail J Roboz from Weill Cornell Medicine in New York discusses the optimal management of acute myeloid leukemia and myelodysplastic syndromes.
Meet The Professor: Optimizing the Management of Acute Myeloid Leukemia and Myelodysplastic Syndromes — Part 1 of a 3-Part Series
October 20, 2023 22:43 - 1 hour - 49.5 MBDr Naval Daver from The University of Texas MD Anderson Cancer Center in Houston, Texas, discusses current and emerging optimal management approaches for patients with acute myeloid leukemia and myelodysplastic syndromes.
What Clinicians Want to Know About the Management of Relapsed/Refractory Mantle Cell Lymphoma
October 19, 2023 18:23 - 1 hour - 49.3 MBDr Toby A Eyre from the Oxford University Hospitals NHS Foundation Trust in Oxford, United Kingdom, and Dr Brad S Kahl from Siteman Cancer Center in St Louis, Missouri, discuss the management of relapsed/refractory mantle cell lymphoma.
Oncology Today with Dr Neil Love: Key Presentations on Multiple Myeloma from Recent Major Oncology/Hematology Conferences
October 18, 2023 18:40 - 1 hour - 63.9 MBDr Joseph Mikhael from the City of Hope Cancer Center in Phoenix, Arizona, discusses recent updates and future directions in the management of newly diagnosed and relapsed/refractory multiple myeloma.
Oncology Today with Dr Neil Love: Bispecific Antibodies in the Management of Non-Hodgkin Lymphoma with Dr Matthew Matasar
October 12, 2023 18:31 - 46 minutes - 37.3 MBDr Matthew Matasar from the Rutgers Cancer Institute of New Jersey in New York, New York, discusses the current and future role of CD20 x CD3 bispecific antibodies in the management of non-Hodgkin lymphoma.
What Clinicians Want to Know About Anti-CD38 Antibodies in the Management of Multiple Myeloma
October 09, 2023 17:02 - 47 minutes - 27.3 MBProf Philippe Moreau from the University Hospital of Nantes in France discusses anti-CD38 antibody-based treatment approaches for newly diagnosed and relapsed/refractory multiple myeloma, moderated by Dr Neil Love.
Oncology Today with Dr Neil Love: Blastic Plasmacytoid Dendritic Cell Neoplasm
October 05, 2023 17:51 - 33 minutes - 19.5 MBDr Naveen Pemmaraju from the University of Texas MD Anderson Cancer Center in Houston, Texas, discusses current and emerging management approaches for blastic plasmacytoid dendritic cell neoplasms.
Oncology Today with Dr Neil Love: Emerging Role of CELMoDs (Cereblon E3 Ligase Modulators) and Other Novel Approaches to Targeting Protein Degradation Pathways in Multiple Myeloma
September 28, 2023 17:37 - 39 minutes - 22.5 MBDr Paul G Richardson from Dana-Farber Cancer Institute in Boston discusses the emerging role of CELMoDs and other novel approaches to targeting protein degradation pathways in the treatment of multiple myeloma.
What Clinicians Want to Know About Toxicity Considerations Associated with BTK Inhibitors
September 22, 2023 22:29 - 1 hour - 36 MBDr Nicole Lamanna from the Columbia University Herbert Irving Comprehensive Cancer Center in New York, New York, and Dr William G Wierda from The University of Texas MD Anderson Cancer Center in Houston, Texas, discuss the spectrum of toxicities associated with BTK inhibitors and strategies for their mitigation and management for patients with chronic lymphocytic leukemia and mantle cell lymphoma.
Inside the Issue: The Current and Future Role of CD20 x CD3 Bispecific Antibodies in the Management of Non-Hodgkin Lymphoma
September 14, 2023 17:14 - 1 hour - 34.8 MBDr Martin Hutchings from Rigshospitalet, Copenhagen University Hospital in Copenhagen, Denmark, and Dr Loretta Nastoupil from The University of Texas MD Anderson Cancer Center in Houston, Texas, discuss the current and future role of CD20 x CD3 bispecific antibodies in the management of non-Hodgkin lymphoma.
Oncology Today with Dr Neil Love: Role of BTK Inhibitors in Patients with Mantle Cell Lymphoma
August 31, 2023 18:37 - 42 minutes - 39 MBFeaturing a discussion on BTK inhibitors for the management of mantle cell lymphoma with Dr Michael Wang, moderated by Dr Neil Love.
Meet The Professor: Optimizing the Management of Soft Tissue Sarcoma and Related Connective Tissue Disorders — Part 2 of a 2-Part Series
August 30, 2023 18:14 - 1 hour - 35.4 MBDr Richard F Riedel from Duke Cancer Institute in Durham, North Carolina, discusses approved and novel treatment approaches for soft tissue sarcoma, moderated by Dr Neil Love.
Oncology Today with Dr Neil Love: Special Edition — Key Presentations on Chronic Lymphocytic Leukemia and Lymphoma from Recent Major Oncology/Hematology Conferences
August 29, 2023 18:09 - 36 minutes - 20.8 MBDr Jeremy Abramson from Massachusetts General Hospital in Boston discusses key presentations on chronic lymphocytic leukemia and lymphomas from recent oncology/hematology conferences.
Inside the Issue: Integrating Bispecific Antibodies into the Management of Multiple Myeloma — Patient Selection and Toxicity Management
August 23, 2023 18:07 - 1 hour - 34.9 MBDr Hans Lee from The University of Texas MD Anderson Cancer Center in Houston, Texas, and Dr Saad Zafar Usmani from Memorial Sloan Kettering Cancer Center in New York, New York, discuss approved and novel bispecific antibodies and their current and potential roles in the treatment of multiple myeloma.
Oncology Today with Dr Neil Love: Special Edition — What I Tell My Patients About New Treatments and Clinical Trials in Chronic Lymphocytic Leukemia
August 18, 2023 19:37 - 1 hour - 63.6 MBDr Kerry Rogers from the Ohio State University in Columbus, Ohio, discusses the education and care of patients with chronic lymphocytic leukemia
Inside the Issue: Novel Agents, Approaches and Strategies in the Management of Higher-Risk Myelodysplastic Syndromes
August 02, 2023 17:20 - 1 hour - 57.9 MBFeaturing perspectives from Dr Guillermo Garcia-Manero and Dr David Sallman, moderated by Dr Neil Love.
Oncology Today with Dr Neil Love: Immune Thrombocytopenia Edition
July 31, 2023 17:51 - 29 minutes - 27 MBDr Hanny Al-Samkari from Harvard Medical School in Boston, Massachusetts, discusses the presentation and management of immune thrombocytopenia.
Oncology Today with Dr Neil Love: Management of Paroxysmal Nocturnal Hemoglobinuria
July 26, 2023 18:15 - 42 minutes - 39.3 MBFeaturing a discussion on the biology and treatment of paroxysmal nocturnal hemoglobinuria with Dr Carlos de Castro, moderated by Dr Neil Love.
Meet The Professor: The Current and Future Management of Non-Hodgkin Lymphoma
July 10, 2023 17:41 - 1 hour - 56.2 MBFeaturing a discussion on the management of non-Hodgkin lymphoma with Dr Ian W Flinn, moderated by Dr Neil Love.
Meet The Professor: Optimizing the Management of Soft Tissue Sarcoma and Related Connective Tissue Disorders — Part 1 of a 2-Part Series
June 16, 2023 17:38 - 1 hour - 56.2 MBFeaturing a discussion on the management of soft tissue sarcoma and related connective tissue disorders with Dr Brian Van Tine, moderated by Dr Neil Love.
Oncology Today with Dr Neil Love: Key Presentations from the 64th American Society of Hematology (ASH) Annual Meeting: Multiple Myeloma Edition
April 19, 2023 17:50 - 1 hour - 68.4 MBFeaturing a discussion on newly presented data in multiple myeloma from the 2022 ASH Annual Meeting, with Dr Jacob Laubach, moderated by Dr Neil Love.
Oncology Today with Dr Neil Love — Key Presentations from the 64th American Society of Hematology (ASH) Annual Meeting: Chronic Lymphocytic Leukemia Edition
April 12, 2023 17:14 - 1 hour - 73 MBFeaturing a discussion on chronic lymphocytic leukemia studies presented at ASH 2022 with Dr John Allan, moderated by Dr Neil Love.
Recent Advances and Future Directions in Chronic Lymphocytic Leukemia and Lymphomas — With Dr Danielle Brander and Craig Moskowitz (Proceedings from a Symposium in Partnership with NCOA and SCOS)
March 17, 2023 19:34 - 59 minutes - 54.5 MBProceedings from a daylong symposium hosted in partnership with North Carolina Oncology Association and the South Carolina Oncology Society, featuring key clinical presentations and papers in breast cancer, gastrointestinal cancers, genitourinary cancers, chronic lymphocytic leukemia and lymphomas, gynecologic cancers and lung cancer. Featuring perspectives from Drs Tanios Bekaii-Saab, Michael Birrer, Danielle Brander, Harold Burstein, Ibiayi Dagogo-Jack, Virginia Kaklamani, Stephen Liu, Ursu...
Oncology Today with Dr Neil Love: Key Presentations in Hodgkin and Non-Hodgkin Lymphomas from the 2022 ASH Annual Meeting
March 02, 2023 20:46 - 1 hour - 80.8 MBFeaturing a discussion on lymphoma studies presented at ASH 2022, with Dr Matthew Lunning, moderated by Dr Neil Love.
Inside the Issue — Optimizing the Management of Adverse Events Associated with BTK Inhibitors
February 23, 2023 17:54 - 1 hour - 58.2 MBProceedings from a webinar on optimizing the management of adverse events associated with BTK inhibitors with Drs Farrukh Awan and Kerry Rogers, moderated by Dr Neil Love.
Year in Review: Clinical Investigator Perspectives on the Most Relevant New Data Sets and Advances in Hodgkin and Non-Hodgkin Lymphomas
February 18, 2023 01:57 - 1 hour - 58.3 MBProceedings from our Year in Review webinar on the management of lymphomas. Featuring perspectives from Drs Christopher Flowers and Laurie Sehn, moderated by Dr Neil Love.
Meet The Professor: Optimizing the Management of Multiple Myeloma — Part 4 of a 4-Part Series
February 14, 2023 18:27 - 1 hour - 55.9 MBFeaturing a discussion on the treatment of multiple myeloma with Dr Noopur Raje, moderated by Dr Neil Love.
Oncology Today with Dr Neil Love: Key Presentations on Myeloproliferative Neoplasms from the 2022 ASH Annual Meeting
February 09, 2023 17:41 - 1 hour - 72.5 MBFeaturing a discussion on newly presented data with myelofibrosis, polycythemia vera and essential thrombocythemia with Dr Srdan Verstovsek, moderated by Dr Neil Love.
Oncology Today with Dr Neil Love: Advances in Diffuse Large B-Cell Lymphoma
February 06, 2023 19:01 - 43 minutes - 39.9 MBFeaturing a discussion on recent data with targeted therapies for the treatment of diffuse large B-cell lymphoma with Dr Gilles Salles, moderated by Dr Neil Love.
Oncology Today with Dr Neil Love: Key Presentations in Acute Myeloid Leukemia and Myelodysplastic Syndromes from the 2022 ASH Annual Meeting
February 02, 2023 19:02 - 1 hour - 64.2 MBFeaturing a discussion on newly presented data in acute myeloid leukemia and myelodysplastic syndromes from the 2022 ASH Annual Meeting with Dr Richard Stone, moderated by Dr Neil Love.
Year in Review: Clinical Investigator Perspectives on the Most Relevant New Data Sets and Advances in Multiple Myeloma
February 01, 2023 18:11 - 1 hour - 59.3 MBProceedings from our Year in Review webinar on the management of multiple myeloma. Featuring perspectives from Drs Joseph Mikhael and Ajay Nooka, moderated by Dr Neil Love.
Meet The Professor: Optimizing the Management of Multiple Myeloma — Part 3 of a 4-Part Series
January 19, 2023 17:21 - 1 hour - 56.3 MBFeaturing a discussion on the treatment of multiple myeloma with Dr Shaji Kumar, moderated by Dr Neil Love.
What Clinicians Want to Know: Addressing Current Questions and Controversies in the Management of Acute Myeloid Leukemia
January 13, 2023 19:00 - 1 hour - 55.2 MBFeaturing perspectives from Drs Courtney DiNardo and Mark Levis, moderated by Dr Neil Love.
Can the Compelling Power of Virtual Education Assist in Reducing Cancer Care Disparities, Particularly in Clinical Trial Participation?
December 29, 2022 17:29 - 1 hour - 55.6 MBFeaturing perspectives from Drs Shaachi Gupta, Zanetta Lamar and Estelamari Rodriguez, moderated by Dr Neil Love.
BCMA-Directed Therapy in Multiple Myeloma: Expert Opinions and Patient Perspectives — Part 2 of a 2-Part Series
December 15, 2022 15:16 - 1 hour - 56 MBFeaturing a discussion on the treatment of multiple myeloma with Dr Vincent Rajkumar, moderated by Dr Neil Love.
Oncology Today with Dr Neil Love: Amyloid Light Chain (AL) Amyloidosis
December 06, 2022 17:57 - 42 minutes - 38.8 MBFeaturing a discussion on the biology, presentation and management of AL amyloidosis with Dr Jeffrey A Zonder, moderated by Dr Neil Love.
Meet The Professor: Optimizing the Management of Multiple Myeloma — Part 2 of a 4-Part Series
December 02, 2022 22:13 - 1 hour - 59 MBFeaturing a discussion on the treatment of multiple myeloma with Dr Paul Richardson, moderated by Dr Neil Love.
Oncology Today with Dr Neil Love: Novel Agents and Strategies in Myelofibrosis
December 01, 2022 18:50 - 41 minutes - 38.1 MBFeaturing a discussion on current treatments and future directions in the care of patients with myelofibrosis with Dr Ruben Mesa, moderated by Dr Neil Love.